Europe Moves to Make Drug Trial Data More Transparent

Drug researchers in Europe would be required to publish results from all medical trials under a proposed law that the European Parliament will vote on Wednesday. The new rules are meant to curtail pharma companies from cherry-picking favorable studies to get new medicines approved.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.